Search research articles
Contact Us
Filters
Showing results (61-70 of 134) with videos related to
Page
of 14
Sort By:
Frontiers in Immunology
|
June 21, 2021
Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages
Bart G J Moerings, Priscilla de Graaff, Matthew Furber, et al.
Iscience
|
January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data
Levi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Human Gene Therapy
|
October 1, 2011
T-cell receptor gene therapy in human melanoma-bearing immune-deficient mice: human but not mouse T cells recapitulate outcome of clinical studies
Trudy Straetemans, Miriam Coccoris, Cor Berrevoets, et al.
International Journal of Nanomedicine
|
March 30, 2016
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
Mesha Saeed, Mandy van Brakel, Sara Zalba, et al.
Cancer Research
|
December 10, 2009
Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors
Sara Bobisse, Maria Rondina, Anna Merlo, et al.
Npj Imaging
|
July 3, 2025
TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients
Hayri E Balcioglu, Rebecca Wijers, Marcel Smid, et al.
International Journal of Nanomedicine
|
April 6, 2026
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma
Ziyun Cheng, Mohamadreza Amin, Mandy van Brakel, et al.
Cancers
|
March 25, 2022
Rintatolimod (Ampligen<sup>®</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program
Hassana El Haddaoui, Rianne Brood, Diba Latifi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2014
Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment
Trudy Straetemans, Cor Berrevoets, Miriam Coccoris, et al.
Frontiers in Immunology
|
June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
Gitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 134) with videos related to
Sort By:
Page
of 14
Frontiers in Immunology
|
June 21, 2021
Continuous Exposure to Non-Soluble β-Glucans Induces Trained Immunity in M-CSF-Differentiated Macrophages
Bart G J Moerings, Priscilla de Graaff, Matthew Furber, et al.
Iscience
|
January 2, 2023
Alternative normalization and analysis pipeline to address systematic bias in NanoString GeoMx Digital Spatial Profiling data
Levi van Hijfte, Marjolein Geurts, Wies R Vallentgoed, et al.
Human Gene Therapy
|
October 1, 2011
T-cell receptor gene therapy in human melanoma-bearing immune-deficient mice: human but not mouse T cells recapitulate outcome of clinical studies
Trudy Straetemans, Miriam Coccoris, Cor Berrevoets, et al.
International Journal of Nanomedicine
|
March 30, 2016
Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody
Mesha Saeed, Mandy van Brakel, Sara Zalba, et al.
Cancer Research
|
December 10, 2009
Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors
Sara Bobisse, Maria Rondina, Anna Merlo, et al.
Npj Imaging
|
July 3, 2025
TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients
Hayri E Balcioglu, Rebecca Wijers, Marcel Smid, et al.
International Journal of Nanomedicine
|
April 6, 2026
Multivalent Atezolizumab-Liposome Conjugates as Active Immunotherapeutic Platforms for Enhanced PD-L1 Blockade in Melanoma
Ziyun Cheng, Mohamadreza Amin, Mandy van Brakel, et al.
Cancers
|
March 25, 2022
Rintatolimod (Ampligen<sup>®</sup>) Enhances Numbers of Peripheral B Cells and Is Associated with Longer Survival in Patients with Locally Advanced and Metastasized Pancreatic Cancer Pre-Treated with FOLFIRINOX: A Single-Center Named Patient Program
Hassana El Haddaoui, Rianne Brood, Diba Latifi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 4, 2014
Recurrence of melanoma following T cell treatment: continued antigen expression in a tumor that evades T cell recruitment
Trudy Straetemans, Cor Berrevoets, Miriam Coccoris, et al.
Frontiers in Immunology
|
June 21, 2021
Vγ9Vδ2 T Cells Concurrently Kill Cancer Cells and Cross-Present Tumor Antigens
Gitte Holmen Olofsson, Manja Idorn, Ana Micaela Carnaz Simões, et al.
Page
of 14